1-(2-(5-(4-(4-aminobutyl)-1H-1,2,3-triazol-1-yl)-2-(4-(2-(naphthalen-1-yl)ethyl)thiazol-2-yl)phenoxy)ethyl)imidazolidin-2-one 2,2,2-trifluoroacetic acid

ID: ALA5287925

Max Phase: Preclinical

Molecular Formula: C34H36F3N7O4S

Molecular Weight: 581.75

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  NCCCCc1cn(-c2ccc(-c3nc(CCc4cccc5ccccc45)cs3)c(OCCN3CCNC3=O)c2)nn1.O=C(O)C(F)(F)F

Standard InChI:  InChI=1S/C32H35N7O2S.C2HF3O2/c33-15-4-3-9-25-21-39(37-36-25)27-13-14-29(30(20-27)41-19-18-38-17-16-34-32(38)40)31-35-26(22-42-31)12-11-24-8-5-7-23-6-1-2-10-28(23)24;3-2(4,5)1(6)7/h1-2,5-8,10,13-14,20-22H,3-4,9,11-12,15-19,33H2,(H,34,40);(H,6,7)

Standard InChI Key:  DFGNSXJTRCZIBT-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 49 53  0  0  0  0  0  0  0  0999 V2000
    6.5142    0.0685    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.7996   -0.3436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0849    0.0685    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3702   -0.3436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6556    0.0685    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9410   -0.3436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1988   -0.0138    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6492   -0.6185    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8245   -0.5360    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3573   -1.1957    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4672   -1.1132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8245   -0.3711    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6216   -0.2886    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1713   -0.8933    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9410   -0.5635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6556   -0.9758    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3702   -0.5635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0848   -0.9758    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7995   -0.5635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5142   -0.9758    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5142   -1.8003    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7995   -2.2126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0848   -1.8003    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8585    0.2610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0339    0.4259    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3298    0.3159    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6596    1.0581    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4842    1.1406    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8140    1.8827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6386    1.9926    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0509    2.7072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7211    3.4493    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8480    2.5148    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9304    1.7178    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1883    1.3605    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4947    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0614   -1.3331    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8585   -1.1681    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3730   -2.2122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3730   -3.0376    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0831   -3.4493    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7995   -3.0412    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7534    2.0466    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.4680    1.6343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4680    0.8098    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.7534    1.2221    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.1826    2.0466    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8972    1.6343    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1826    2.8712    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  3  1  0
  5  4  1  0
  6  5  1  0
  6  7  2  0
  8  7  1  0
  8  9  1  0
  9 10  2  0
 11 10  1  0
 12 11  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 20 19  1  0
 21 20  2  0
 22 21  1  0
 23 22  2  0
 18 23  1  0
 15 24  2  0
 25 24  1  0
 25 13  1  0
 26 12  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 31 30  1  0
 31 32  2  0
 31 33  1  0
 33 34  1  0
 34 35  1  0
 35 30  1  0
 36 26  2  0
  9 36  1  0
  8 37  1  0
 37 38  2  0
 38  6  1  0
 23 39  1  0
 40 39  2  0
 41 40  1  0
 42 41  2  0
 22 42  1  0
 44 43  1  0
 44 45  1  0
 44 46  1  0
 47 44  1  0
 47 48  1  0
 47 49  2  0
M  END

Associated Targets(Human)

HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Leishmania infantum (5912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 581.75Molecular Weight (Monoisotopic): 581.2573AlogP: 5.01#Rotatable Bonds: 13
Polar Surface Area: 111.19Molecular Species: BASEHBA: 8HBD: 2
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 13.44CX Basic pKa: 10.20CX LogP: 4.75CX LogD: 2.14
Aromatic Rings: 5Heavy Atoms: 42QED Weighted: 0.19Np Likeness Score: -1.44

References

1. de Lucio H, Revuelto A, Carriles AA, de Castro S, García-González S, García-Soriano JC, Alcón-Calderón M, Sánchez-Murcia PA, Hermoso JA, Gago F, Camarasa MJ, Jiménez-Ruiz A, Velázquez S..  (2022)  Identification of 1,2,3-triazolium salt-based inhibitors of Leishmania infantum trypanothione disulfide reductase with enhanced antileishmanial potency in cellulo and increased selectivity.,  244  [PMID:36332553] [10.1016/j.ejmech.2022.114878]

Source